This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (201)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Lipids and Lipid Disorders  • Alert me on articles by topic

Benoît Lamarche, PhD; André Tchernof, PhD; Pascale Mauriège, PhD; Bernard Cantin, MD; Gilles R. Dagenais, MD; Paul J. Lupien, MD; Jean-Pierre Després, PhD

JAMA. 1998;279:1955-1961.

Context.— Epidemiological studies have established a relationship between cholesterol and low-density lipoprotein cholesterol (LDL-C) concentrations and the risk of ischemic heart disease (IHD), but up to half of patients with IHD may have cholesterol levels in the normal range.

Objective.— To assess the ability to predict the risk of IHD using a cluster of nontraditional metabolic risk factors that includes elevated fasting insulin and apolipoprotein B levels as well as small, dense LDL particles.

Design.— Nested case-control study.

Setting.— Cases and controls were identified from the population-based cohort of the Québec Cardiovascular Study, a prospective study conducted in men free of IHD in 1985 and followed up for 5 years.

Participants.— Incident IHD cases were matched with controls selected from among the sample of men who remained IHD free during follow-up. Matching variables were age, smoking habits, body mass index, and alcohol consumption. The sample included 85 complete pairs of nondiabetic IHD cases and controls.

Main Outcome Measures.— Ability of fasting insulin level, apolipoprotein B level, and LDL particle diameter to predict IHD events, defined as angina, coronary insufficiency, nonfatal myocardial infarction, and coronary death.

Results.— The risk of IHD was significantly increased in men who had elevated fasting plasma insulin and apolipoprotein B levels and small, dense LDL particles, compared with men who had normal levels for 2 of these 3 risk factors (odds ratio [OR], 5.9; 95% confidence interval [CI], 2.3-15.4). Multivariate adjustment for LDL-C, triglycerides, and high-density lipoprotein cholesterol (HDL-C) did not attenuate the relationship between the cluster of nontraditional risk factors and IHD (OR, 5.2; 95% CI, 1.7-15.7). On the other hand, the risk of IHD in men having a combination of elevated LDL-C and triglyceride levels and reduced HDL-C levels was no longer significant (OR, 1.4; 95% CI, 0.5-3.5) after multivariate adjustment for fasting plasma insulin level, apolipoprotein B level, and LDL particle size.

Conclusion.— Results from this prospective study suggest that the measurement of fasting plasma insulin level, apolipoprotein B level, and LDL particle size may provide further information on the risk of IHD compared with the information provided by conventional lipid variables.

From the Lipid Research Center, Laval University Hospital Research Center, Ste-Foy, Québec (Drs Lamarche, Tchernof, Mauriège, Cantin, Lupien, and Després); and the Department of Medicine, University of Montréal, Montréal, Québec (Dr Dagenais).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

C-Reactive Protein Is Elevated 30 Years After Eclamptic Pregnancy
Hubel et al.
Hypertension 2008;51:1499-1505.
ABSTRACT | FULL TEXT  

Metabolic Alterations and Systemic Inflammation in Obstructive Sleep Apnea among Nonobese and Obese Prepubertal Children
Gozal et al.
Am. J. Respir. Crit. Care Med. 2008;177:1142-1149.
ABSTRACT | FULL TEXT  

PROactive: time for a critical appraisal
Betteridge et al.
Eur Heart J 2008;29:969-983.
ABSTRACT | FULL TEXT  

Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance
Despres and Brewer
Eur Heart J Suppl 2008;10:B1-B3.
FULL TEXT  

From individual risk factors and the metabolic syndrome to global cardiometabolic risk
Despres et al.
Eur Heart J Suppl 2008;10:B24-B33.
ABSTRACT | FULL TEXT  

Type 2 Diabetes Without the Atherogenic Metabolic Triad Does Not Predict Angiographically Assessed Coronary Artery Disease in Women
Blackburn et al.
Diabetes Care 2008;31:170-172.
FULL TEXT  

The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndrome
Sniderman
Eur Heart J 2007;28:2563-2564.
FULL TEXT  

Visceral Adipose Tissue Accumulation, Cardiorespiratory Fitness, and Features of the Metabolic Syndrome
Arsenault et al.
Arch Intern Med 2007;167:1518-1525.
ABSTRACT | FULL TEXT  

Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype
Esmaillzadeh et al.
Am. J. Clin. Nutr. 2006;83:36-46.
ABSTRACT | FULL TEXT  

2nd International Symposium on Triglycerides and HDL: Metabolic syndrome
Bloomgarden
Diabetes Care 2005;28:2577-2584.
FULL TEXT  

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Goldberg et al.
Diabetes Care 2005;28:1547-1554.
ABSTRACT | FULL TEXT  

Pathophysiology of dyslipidaemia in the metabolic syndrome
Kolovou et al.
Postgrad. Med. J. 2005;81:358-366.
ABSTRACT | FULL TEXT  

Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women
Tanko et al.
Circulation 2005;111:1883-1890.
ABSTRACT | FULL TEXT  

Biochemical risk markers: a novel area for better prediction of renal risk?
Stuveling et al.
Nephrol Dial Transplant 2005;20:497-508.
FULL TEXT  

Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults
Esmaillzadeh et al.
Am. J. Clin. Nutr. 2005;81:55-63.
ABSTRACT | FULL TEXT  

Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Bairaktari et al.
J CARDIOVASC PHARMACOL THER 2005;10:45-54.
ABSTRACT  

Dyslipidemia and the Metabolic Syndrome
Bloomgarden
Diabetes Care 2004;27:3009-3016.
FULL TEXT  

Metabolic syndrome and effects of conjugated linoleic acid in obesity and lipoprotein disorders: the Quebec experience
Lamarche and Desroches
Am. J. Clin. Nutr. 2004;79:1149S-1152S.
ABSTRACT | FULL TEXT  

Implications of plasma concentrations of adiponectin in patients with coronary artery disease
Nakamura et al.
Heart 2004;90:528-533.
ABSTRACT | FULL TEXT  

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older
Alexander et al.
Diabetes 2003;52:1210-1214.
ABSTRACT | FULL TEXT  

Adiposity and Diabetes
Bloomgarden
Diabetes Care 2002;25:2342-2349.
FULL TEXT  

Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subjects With Dyslipidemia
Chan et al.
Diabetes 2002;51:2377-2386.
ABSTRACT | FULL TEXT  

High Density- and Beta-Lipoprotein Screening for Risk of Coronary Artery Disease in the Context of New Findings on Reverse Cholesterol Transport
Levinson
Annals of Clinical & Laboratory Science 2002;32:123-136.
ABSTRACT | FULL TEXT  

Dietary Mono- and Polyunsaturated Fatty Acids Similarly Affect LDL Size in Healthy Men and Women
Kratz et al.
J. Nutr. 2002;132:715-718.
ABSTRACT | FULL TEXT  

Effects of an Energy-Restrictive Diet With or Without Exercise on Abdominal Fat, Intermuscular Fat, and Metabolic Risk Factors in Obese Women
Janssen et al.
Diabetes Care 2002;25:431-438.
ABSTRACT | FULL TEXT  

Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B
Keulen et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:283-288.
ABSTRACT | FULL TEXT  

Eligibility for Lipid-Lowering Drug Therapy in Primary Prevention: How Do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines Compare?
Gotto and Kuller
Circulation 2002;105:136-139.
FULL TEXT  

Apolipoprotein A-I and B and Stroke Events in a Community-Based Cohort in Taiwan: Report of the Chin-Shan Community Cardiovascular Study
Chien et al.
Stroke 2002;33:39-44.
ABSTRACT | FULL TEXT  

Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study
Lemieux et al.
Arch Intern Med 2001;161:2685-2692.
ABSTRACT | FULL TEXT  

Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity
Pascot et al.
J. Lipid Res. 2001;42:2007-2014.
ABSTRACT | FULL TEXT  

Transplant Coronary Artery Disease: A Novel Model Independent of Cellular Alloimmune Response
Cantin et al.
Circulation 2001;104:2615-2619.
ABSTRACT | FULL TEXT  

Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol
Despres et al.
CMAJ 2001;165:1331-1333.
FULL TEXT  

n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik
Dewailly et al.
Am. J. Clin. Nutr. 2001;74:464-473.
ABSTRACT | FULL TEXT  

Oxidized LDL and HDL: antagonists in atherothrombosis
MERTENS and HOLVOET
FASEB J. 2001;15:2073-2084.
ABSTRACT | FULL TEXT  

Lipid deposition in rats centrally infused with leptin in the presence or absence of corticosterone
Arvaniti et al.
Am. J. Physiol. Endocrinol. Metab. 2001;281:E809-E816.
ABSTRACT | FULL TEXT  

Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-analysis of Controlled Clinical Trials
Boule et al.
JAMA 2001;286:1218-1227.
ABSTRACT | FULL TEXT  

Metabolic cardiovascular syndrome after renal transplantation
Hjelmesath et al.
Nephrol Dial Transplant 2001;16:1047-1052.
ABSTRACT | FULL TEXT  

Abdominal obesity and the "hypertriglyceridaemic waist" phenotype
Little and Byrne
BMJ 2001;322:687-689.
FULL TEXT  

Treatment of obesity: need to focus on high risk abdominally obese patients
Després et al.
BMJ 2001;322:716-720.
FULL TEXT  

Diabetic Dyslipidemia: Causes and Consequences
Goldberg
J. Clin. Endocrinol. Metab. 2001;86:965-971.
FULL TEXT  

Low Triglycerides-High High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease
Jeppesen et al.
Arch Intern Med 2001;161:361-366.
ABSTRACT | FULL TEXT  

An olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets
Pedersen et al.
J. Lipid Res. 2000;41:1901-1911.
ABSTRACT | FULL TEXT  

Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men: A Randomized, Controlled Trial
Ross et al.
ANN INTERN MED 2000;133:92-103.
ABSTRACT | FULL TEXT  

Hypertriglyceridemic Waist : A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?
Lemieux et al.
Circulation 2000;102:179-184.
ABSTRACT | FULL TEXT  

A 33-Year-Old Woman With Morbid Obesity
Atkinson
JAMA 2000;283:3236-3243.
FULL TEXT  

Molecular scanning of the human PPARa gene: association of the L162V mutation with hyperapobetalipoproteinemia
Vohl et al.
J. Lipid Res. 2000;41:945-952.
ABSTRACT | FULL TEXT  

Hypertriglyceridemia and Coronary Heart Disease
Oberman
J. Clin. Endocrinol. Metab. 2000;85:2098-2105.
FULL TEXT  

Small Dense Low-Density Lipoprotein in Japanese Men with Coronary Artery Disease
Koba and Hirano
ANN INTERN MED 2000;132:762-762.
FULL TEXT  

Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Gotto et al.
Circulation 2000;101:477-484.
ABSTRACT | FULL TEXT  

Dietary Glycemic Index and Obesity
Ludwig
J. Nutr. 2000;130:280-280.
ABSTRACT | FULL TEXT  

Oxidative Stress in the Pathogenesis of Preeclampsia
Hubel
Exp. Biol. Med. 1999;222:222-235.
ABSTRACT | FULL TEXT  

Dietary Fiber, Weight Gain, and Cardiovascular Disease Risk Factors in Young Adults
Ludwig et al.
JAMA 1999;282:1539-1546.
ABSTRACT | FULL TEXT  

Pleiotropic Genetic Effects on LDL Size, Plasma Triglyceride, and HDL Cholesterol in Families
Edwards et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:2456-2464.
ABSTRACT | FULL TEXT  

LDL Size in African Americans, Hispanics, and Non-Hispanic Whites : The Insulin Resistance Atherosclerosis Study
Haffner et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:2234-2240.
ABSTRACT | FULL TEXT  

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
Rubins et al.
NEJM 1999;341:410-418.
ABSTRACT | FULL TEXT  

Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth : Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects
Rainwater et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:753-761.
ABSTRACT | FULL TEXT  

Triglycerides and Small, Dense Low-Density Lipoprotein
Enas et al.
JAMA 1998;280:1990-1991.
FULL TEXT  

Coronary Risk Factors: What's Beyond Cholesterol?
JWatch General 1998;1998:2-2.
FULL TEXT